RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7

Objective: To construct and recombine a lentivirus-mediated short hairpin RNA (shRNA) vector targeting NUP88 gene and to observe the effect of silencing NUP88 gene on the biological behavior of MCF-7 cells by RNA interference (RNAi) technology, so as to find a new target for the treatment of breast cancer. Materials and Methods: The recombinant lentiviral vector of NUP88-shRNA was constructed and then transfected into MCF-7 cells. Then, the changes of biological behavior of MCF-7 cells were detected by reverse transcription polymerase chain reaction (RT-PCR), Western-blot, methyl thiazolyl tetrazolium (MTT), flow cytometry, and Transwell assay. Results: The results of RT-PCR and Western-blot showed that the expression of NUP88 mRNA and protein was significantly reduced in NUP88-shRNA group, as compared with that in the blank and negative groups (p < 0.01). The proliferation of MCF-7 cells in the NUP88-shRNA group was prominently reduced after transfected with lentivirus-NUP88-shRNA (p < 0.05). Flow cytometry results showed that the apoptosis rate increased significantly in the NUP88-shRNA group as compared with the other two groups (p < 0.05). After routine culture for 24 hours, the transmembrane cells in the NUP88-shRNA group were notably less than that in the blank or negative control group (p < 0.05). Conclusion: Recombinant NUP88-shRNA lentivirus can successfully inhibit the expression of NUP88 gene in MCF-7 cells and consequently inhibit the proliferation and invasive ability of human breast cancer cells.

NUP88; Human breast cancer cell MCF-7; RNAi; Lentiviral vector

[1] Denic S., Agarwal M.M.: “Breast cancer protection by genomic imprinting in close kin families”. BMC Med. Genet., 2017, 18, 136.

[2] Ye X., He Q., Zhou X.: “Study on the adverse effects following chemotherapy for breast cancer diagnosis during pregnancy: The first case report in China”. Medicine (Baltimore), 2017, 96, e8582.

[3] Wang Y., Zhu J., Gou J., Xiong J., Yang X.: “Phyllodes tumors of the breast in 2 sisters: Case report and review of literature”. Medicine (Baltimore), 2017, 96, e8552.

[4] Jiang Y., He Q., Li S., Shi C., Yang X.: “Reversible severe fatty liver induced by capecitabine: A case report”. Medicine (Baltimore), 2017, 96, e8547.

[5] Jung J.H., Son S.H., Kim D.H., Lee J., Jeong S.Y., Lee S.W., et al.: “CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer”. Medicine (Baltimore), 2017, 96, e8438.

[6] Genenncher B., Lipka V., Petutschnig E.K., Wiermer M.: “Nucleoporin NUP88/MOS7 is required for manifestation of phenotypes associated with the Arabidopsis CHITIN ELICITOR RECEPTOR KINASE1 mutant cerk1-4”. Plant Signal. Behav., 2017, 12, e1313378.

[7] Li J., Zhao J., Li Y.: “Multiple biological processes may be associated with tumorigenesis under NUP88-overexpressed condition”. Genes Chromosomes Cancer, 2017, 56, 117.

[8] Li Y., Zhang X., Ge J., Liu X., Xu S., Zhu Z., et al.: “Can Nup88 expression be associated with atypical endometrial hyperplasia and endometrial cancer? A preliminary study”. Pathol. Res. Pract., 2016, 212, 274.

[9] Naylor R.M., Jeganathan K.B., Cao X., van Deursen J.M.: “Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy”. J. Clin. Invest., 2016, 126, 543.

[10] Park G.T., Frost J.M., Park J.S., Kim T.H., Lee J.S., Oh S.A., et al.: “Nucleoporin MOS7/Nup88 is required for mitosis in gametogenesis and seed development in Arabidopsis”. Proc. Natl. Acad. Sci. U. S. A., 2014, 111, 18393.

[11] Rodrigues T.B., Dhandapani R.K., Duan J.J., Palli S.R.: “RNA interference in the Asian Longhorned Beetle:Identification of Key RNAi Genes and Reference Genes for RT-qPCR”. Sci. Rep., 2017, 7, 8913.

[12] Majumdar R., Rajasekaran K., Cary J.W.: “RNA Interference (RNAi) as a Potential Tool for Control of Mycotoxin Contamination in Crop Plants: Concepts and Considerations”. Front. Plant. Sci., 2017, 8, 200.

[13] Mathur K., Anand A., Dubey S.K., Sanan-Mishra N., Bhatnagar R.K., Sunil S.: “Analysis of chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity”. Sci. Rep., 2016, 6, 38065.

[14] Unniyampurath U., Pilankatta R., Krishnan M.N.: “RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi”. Int. J. Mol. Sci., 2016, 17, 291.

[15] Jorgensen R.A., Cluster P.D., English J., Que Q., Napoli C.A.: “Chalcone synthase co-suppression phenotypes in petunia flowers: comparison of sense vs. antisense constructs and single-copy vs. complex T -DNA sequences”. Plant Mol. Biol., 1996, 31, 957.

[16] Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C.: “Potent and specific genetic interference by double -stranded RNA in Caenorhabditis elegans”. Nature, 1998, 391, 666.

[17] Bobbin M.L., Rossi J.J.: “RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise”. Annu. Rev. Pharmacol. Toxicol., 2016, 56, 103.

[18] Moon S.L., Dodd B.J., Brackney D.E., Wilusz C.J., Ebel G.D., Wilusz J.: “Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery”. Virology, 2015, 485, 322.

[19] Stebbing J., Zhang H., Xu Y., Grothey A., Ajuh P., Angelopoulos N., Giamas G.: “Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics”. Mol. Cell. Proteomics, 2015, 14, 2479.

[20] Agudo D., Gómez-Esquer F., Martínez-Arribas F., Núñez-Villar M.J., Pollán M., Schneider J.: “Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer”. Int. J. Cancer, 2004, 10, 717.

[21] Schneider J., Martnez-Arribas F., Torrejon R.: “Nup88 Expression is Associated With Myometrial Invasion in Endometrial Carcinoma”. Int. J. Gynecol. Cancer, 2010, 20, 804.

[22] Zhao Z.R., Zhang Z.Y., He X.Q., Hu Y.M., Tian Y.F., Zhang L.J., Sun X.F.: “Nup88 mRNA overexpression in colorectal cancers and relationship with p53”. Cancer Biomark., 2010, 8, 73.

[23] Cheng Y.T., Germain H., Wiermer M., Bi D., Xu F., García A.V.: “Nuclear pore complex component MOS7/Nup88 is required for innate immunity and nuclear accumulation of defense regulators in Arabidopsis”. Plant Cell, 2009, 21, 2503.

[24] Shu W.X., Chen Y., He J.: “Effects of gambogic acid on the regulation of nucleoporin Nup88 in HL-60 cells”. Zhonghua Zhong Liu Za Zhi, 2008, 30, 484.

[25] Andres-Hernando A., Lanaspa M.A., Rivard C.J., Berl T.: “Nucleoporin 88 (Nup88) is regulated by hypertonic stress in kidney cells to retain the transcription factor tonicity enhancer-binding protein (TonEBP) in the nucleus”. J. Biol. Chem., 2008, 283, 25082.